EMEA-002168-PIP01-17-M03
Key facts
| Invented name |
Zolgensma
|
| Active substance |
onasemnogene abeparvovec
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0379/2020
|
| PIP number |
EMEA-002168-PIP01-17-M03
|
| Pharmaceutical form(s) |
Solution for injection/infusion
|
| Condition(s) / indication(s) |
Treatment of spinal muscular atrophy
|
| Route(s) of administration |
|
| Contact for public enquiries |
AveXis EU Limited
E-mail: medinfo.emea@avexis.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|